Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 339

    1.

    1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).

    Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R, Mathieu C.

    Diabetes. 2000 Aug;49(8):1301-7.PMID: 10923629 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.

    Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH.

    Diabetes. 1997 Dec;46(12):1975-82. Erratum in: Diabetes 1998 Feb;47(2):303. PMID: 9392483 [PubMed - indexed for MEDLINE]Related articles

    3.

    Th1-like dominance in high-risk first-degree relatives of type I diabetic patients.

    Karlsson MG, Lawesson SS, Ludvigsson J.

    Diabetologia. 2000 Jun;43(6):742-9.PMID: 10907120 [PubMed - indexed for MEDLINE]Related articles

    4.

    Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.

    Chen C, Lee WH, Yun P, Snow P, Liu CP.

    J Immunol. 2003 Jul 15;171(2):733-44.PMID: 12847240 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.

    Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, Serreze DV.

    J Immunol. 2001 Feb 1;166(3):2122-32.PMID: 11160264 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

    Maron R, Melican NS, Weiner HL.

    J Autoimmun. 1999 Jun;12(4):251-8.PMID: 10330296 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

    Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL.

    J Exp Med. 1996 Apr 1;183(4):1561-7.PMID: 8666914 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.

    Tisch R, Wang B, Atkinson MA, Serreze DV, Friedline R.

    J Immunol. 2001 Jun 1;166(11):6925-36.PMID: 11359854 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

    Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

    Diabetes. 1999 Nov;48(11):2150-6.PMID: 10535448 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.

    Saï P, Rivereau AS, Granier C, Haertlé T, Martignat L.

    Clin Exp Immunol. 1996 Aug;105(2):330-7.PMID: 8706342 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

    Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L.

    J Immunol. 2000 Dec 15;165(12):6748-55.PMID: 11120794 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

    Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

    J Immunol. 2001 Mar 1;166(5):2982-91.PMID: 11207247 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses.

    Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, Van Loveren H.

    Immunology. 1999 Jul;97(3):506-14.PMID: 10447774 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.

    Trembleau S, Penna G, Gregori S, Gately MK, Adorini L.

    Eur J Immunol. 1997 Sep;27(9):2330-9.PMID: 9341777 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.

    Jyonouchi H, Sun S, Winship T, Kuchan MJ.

    J Nutr. 2001 Apr;131(4):1165-70.PMID: 11285320 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Balance of GAD65-specific IL-10 production and polyclonal Th1-type response in type 1 diabetes.

    Funae O, Shimada A, Tokui M, Takei I, Saruta T.

    Autoimmunity. 2001;34(1):45-52.PMID: 11681492 [PubMed - indexed for MEDLINE]Related articles

    19.

    1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization.

    Van Der Stede Y, Verfaillie T, Cox E, Verdonck F, Goddeeris BM.

    Clin Exp Immunol. 2004 Mar;135(3):380-90.PMID: 15008969 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.

    Ploix C, Bergerot I, Fabien N, Perche S, Moulin V, Thivolet C.

    Diabetes. 1998 Jan;47(1):39-44.PMID: 9421372 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data